Contact
searchSearch
HMP Global

News

AI & Imaging
With Help of AI, CT Scans Taken to Look for Tumors, Bleeding, or Infections, Also Revealed Calcium Buildup in Arteries
01/17/2025
"Instead of relying on dedicated CT scans of coronary arteries, which are rare and not always covered by insurance, to find heart disease, we seek to use AI to help screen abdominal CT scans that are done for many reasons," said study senior...
"Instead of relying on dedicated CT scans of coronary arteries, which are rare and not always covered by insurance, to find heart disease, we seek to use AI to help screen abdominal CT scans that are done for many reasons," said study senior...
"Instead of relying on dedicated...
01/17/2025
Cath Lab Digest
human induced pluripotent stem cells (hiPSCs)
Cell-Based Therapy Improves Outcomes in Pig Model of Heart Attacks
01/17/2025
"In our current study, at week 4 after ischemia/reperfusion, we observed a significant 35.8 percent decrease in the infarct area in the hearts treated with the KO/OEhiPSC-cardiomyocyte spheroids," said Jianyi "Jay" Zhang, MD, PhD.
"In our current study, at week 4 after ischemia/reperfusion, we observed a significant 35.8 percent decrease in the infarct area in the hearts treated with the KO/OEhiPSC-cardiomyocyte spheroids," said Jianyi "Jay" Zhang, MD, PhD.
"In our current study, at week 4...
01/17/2025
Cath Lab Digest
Noise Pollution
Study: Exposure to Aircraft Noise Linked to Worse Heart Function
01/17/2025
The study, published in the Journal of the American College of Cardiology (JACC), looked at detailed heart imaging data from 3,635 people who lived close to four major airports in England.
The study, published in the Journal of the American College of Cardiology (JACC), looked at detailed heart imaging data from 3,635 people who lived close to four major airports in England.
The study, published in...
01/17/2025
Cath Lab Digest
HCM Diagnosis
JACC: Women May Be Missing Diagnosis of Hypertrophic Cardiomyopathy (HCM) Due to Guidelines That Don't Account for Natural Differences in Sex and Body Size
01/17/2025
Women may be missing a diagnosis of a potentially deadly heart condition due to guidelines that don't account for natural differences in sex and body size, according to a new study led by UCL (University College London) researchers and funded...
Women may be missing a diagnosis of a potentially deadly heart condition due to guidelines that don't account for natural differences in sex and body size, according to a new study led by UCL (University College London) researchers and funded...
Women may be missing a diagnosis...
01/17/2025
Cath Lab Digest
Cardiac Rehab
Cost of Initial Cardiac Rehab Session Strongest Predictor of Lower Attendance
01/17/2025
In a national study of over 40,000 people with Medicare and commercial insurance, 81.6% of patients did not have to pay for their initial cardiac rehabilitation session. The medically supervised program lasts up to 36 sessions.
In a national study of over 40,000 people with Medicare and commercial insurance, 81.6% of patients did not have to pay for their initial cardiac rehabilitation session. The medically supervised program lasts up to 36 sessions.
In a national study of over...
01/17/2025
Cath Lab Digest
Left Atrial Appendage Occlusion
Sub-Analysis From OPTION Clinical Trial Highlights Consistent Safety and Efficacy Outcomes With the WATCHMAN FLX™ Left Atrial Appendage Closure Device Post Cardiac Ablation in Both Concomitant and Sequential Procedures
01/17/2025
Boston Scientific News Boston Scientific Corporation announced data supporting the use of the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device during a late-breaking science session at AF Symposium 2025. A prespecified...
Boston Scientific News Boston Scientific Corporation announced data supporting the use of the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device during a late-breaking science session at AF Symposium 2025. A prespecified...
Boston Scientific News Boston...
01/17/2025
Cath Lab Digest
Hypertension
Medtronic Announces CMS National Coverage Analysis for Symplicity™ Spyral Renal Denervation System
01/14/2025
The Symplicity Spyral RDN system, approved by the U.S. FDA in November 2023, is an innovative, minimally invasive procedure that delivers radiofrequency energy to nerves near the kidneys that can become overactive and contribute to high blood...
The Symplicity Spyral RDN system, approved by the U.S. FDA in November 2023, is an innovative, minimally invasive procedure that delivers radiofrequency energy to nerves near the kidneys that can become overactive and contribute to high blood...
The Symplicity Spyral RDN...
01/14/2025
Cath Lab Digest
COffee and CV Disease
Morning-Only Coffee Linked With 31% Lower Risk of Dying From Cardiovascular Disease
01/14/2025
In this study, the health benefits of coffee consumption was limited to the morning hours only-from 4 am up to noon.
In this study, the health benefits of coffee consumption was limited to the morning hours only-from 4 am up to noon.
In this study, the health...
01/14/2025
Cath Lab Digest
Pulmonary Embolism
AngioDynamics Announces Publication of APEX-AV Trial Results in JSCAI
01/13/2025
Peer-reviewed data highlights successful clinical study with 35.5% clot burden reduction, validating the safety, efficacy, and efficiency of AlphaVac F1885 System in pulmonary embolism treatment. LATHAM, N.Y.--(BUSINESS WIRE)--Jan. 13,...
Peer-reviewed data highlights successful clinical study with 35.5% clot burden reduction, validating the safety, efficacy, and efficiency of AlphaVac F1885 System in pulmonary embolism treatment. LATHAM, N.Y.--(BUSINESS WIRE)--Jan. 13,...
Peer-reviewed data highlights...
01/13/2025
Vascular Disease Management
Thrombectomy
Inquis Medical Completes Enrollment in U.S. Pivotal IDE Trial of the Aventus Thrombectomy System Designed to Treat Patients With Pulmonary Embolism
01/13/2025
MENLO PARK, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Inquis Medical, a leading innovator in venous thromboembolic disease treatment, today announced completion of patient enrollment in its AVENTUS Clinical Trial, a pivotal Investigational...
MENLO PARK, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Inquis Medical, a leading innovator in venous thromboembolic disease treatment, today announced completion of patient enrollment in its AVENTUS Clinical Trial, a pivotal Investigational...
MENLO PARK, Calif., Jan. 13,...
01/13/2025
Vascular Disease Management

Supplements

Auryon Supplement
Product Monograph
The Auryon Laser in Treating Symptomatic Infrainguinal Arterial Disease
OBL Corner Compendium
Supplement
OBL Corner Best of 2021 Print Compendium
This Compendium features the most popular articles from VDM's OBL Corner in 2021.  Sponsored by Medtronic. 
CLD Supplement with Siemens Healthineers and University Hospitals in Cleveland
Supplement
A Central Hub for Structural Heart Intervention Facilitates Collaboration, Innovation, and Patient Satisfaction at UH Harrington HVI: Partnering With Siemens Healthineers for Advanced Imaging, Lower Radiation, and Greater Efficiencies of Care
Partnering With Siemens Healthineers for Advanced Imaging, Lower Radiation, and Greater Efficiencies of Care

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use